Table of Contents Table of Contents
Previous Page  460 / 604 Next Page
Information
Show Menu
Previous Page 460 / 604 Next Page
Page Background

Opportunity cost in palliation of NSCLC

Median survival with inoperable NSCLC

Ø

PS 2 - 3 or mets:

120 days

Ø

Asymptomatic

§

No treatment; no toxicity; no loss of survival

Ø

Symptomatic

§

1 treatment for equivalent symptom control and

toxicity to longer treatment

§

BUT…will any patients live longer with 20Gy/39Gy